Cargando…

Current progress in cancer treatment by targeting FGFR signaling

Detalles Bibliográficos
Autores principales:	Du, Sicheng, Zhang, Ying, Xu, Jianming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466438/ https://www.ncbi.nlm.nih.gov/pubmed/37493315 http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0137

Ejemplares similares

Progress in targeted therapy for breast cancer
por: Ju, Jie, et al.
Publicado: (2018)

A ‘Goldmine’ for digging cancer-specific targets: the genes essential for embryo development but non-essential for adult life
por: Yu, Xiaobin, et al.
Publicado: (2020)

Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling
por: Xiao, Jin-Fen, et al.
Publicado: (2021)

Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
por: Gordon, Anderley, et al.
Publicado: (2022)

Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients
por: Zhou, Wen-Ya, et al.
Publicado: (2016)

The interplay between NCAM and FGFR signalling underlies ovarian cancer progression
por: Colombo, N, et al.
Publicado: (2011)

Family Herpesviridae and neuroinfections: current status and research in progress
por: Carneiro, Vanessa Cristine de Souza, et al.
Publicado: (2022)

CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
por: Huang, Xinxin, et al.
Publicado: (2022)

Targeting the FGFR signaling pathway in cholangiocarcinoma: promise or delusion?
por: Wang, Jing, et al.
Publicado: (2020)

Recent progress in targeting cancer
por: Demidenko, Zoya N., et al.
Publicado: (2011)

Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis
por: Wu, Xinle, et al.
Publicado: (2009)

Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
por: Wang, Cong, et al.
Publicado: (2019)

The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling
por: Zecchini, Silvia, et al.
Publicado: (2011)

FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer
por: Yang, Ying, et al.
Publicado: (2020)

Circ_0000885 Enhances Osteosarcoma Progression by Increasing FGFR1 Expression via Sponging MiR-1294
por: Chen, Yinxian, et al.
Publicado: (2020)

Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
por: Liu, Guihong, et al.
Publicado: (2021)

Current progress and trends in musculoskeletal research: Highlights of NSFC-CUHK academic symposium on bone and joint degeneration and regeneration
por: Tuan, Rocky S., et al.
Publicado: (2022)

The landscape of neuroscience research in Africa: current state, progress, and challenges; a perspective
por: Aderinto, Nicholas, et al.
Publicado: (2023)

Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment
por: Ratti, Margherita, et al.
Publicado: (2023)

Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?
por: Lippert, Theodor H, et al.
Publicado: (2014)

Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments
por: Arafat, Yasser, et al.
Publicado: (2022)

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy
por: Rudzińska, Magdalena, et al.
Publicado: (2021)

FGFR-TKI resistance in cancer: current status and perspectives
por: Yue, Sitong, et al.
Publicado: (2021)

Current and Future Treatment of Retinitis Pigmentosa
por: Cross, Nancy, et al.
Publicado: (2022)

Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression
por: Liu, Yanan, et al.
Publicado: (2020)

The state of macro-energy systems research: Common critiques, current progress, and research priorities
por: Moglen, Rachel, et al.
Publicado: (2023)

Current progress, challenges, and future perspectives of language models for protein representation and protein design
por: Huang, Tao, et al.
Publicado: (2023)

Epigenetic Inheritance: Impact for Biology and Society—recent progress, current questions and future challenges
por: Arzate-Mejía, Rodrigo G, et al.
Publicado: (2022)

Deciphering role of FGFR signalling pathway in pancreatic cancer
por: Kang, Xiaodiao, et al.
Publicado: (2019)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
por: Weickhardt, Andrew J., et al.
Publicado: (2022)

MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3
por: Long, Xinghua, et al.
Publicado: (2020)

Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models
por: Zhang, H, et al.
Publicado: (2014)

Early detection of gastric cancer in China: progress and opportunities
por: Xu, Hengmin, et al.
Publicado: (2022)

Complexity of FGFR signalling in metastatic urothelial cancer
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2015)

Targeting PDGF Signaling in Carcinoma-Associated Fibroblasts Controls Cervical Cancer in Mouse Model
por: Jain, Rakesh K, et al.
Publicado: (2008)

Self-aggregating TIAF1 in lung cancer progression
por: Hong, Qunying, et al.
Publicado: (2013)

Biological Significance and Targeting of the FGFR Axis in Cancer
por: Chioni, Athina-Myrto, et al.
Publicado: (2021)

Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR Approaches
por: Pagano, Katiuscia, et al.
Publicado: (2022)

FGF/FGFR signaling pathway involved resistance in various cancer types
por: Zhou, Yangyang, et al.
Publicado: (2020)

Current stem cell treatments for spinal cord injury
por: Vawda, R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_aa7n7t4t8mack60soot2q10cl1